### ## Company Overview
OpenEvidence ("OpenEvidence") is a Boston, MAâ€“based medical information platform founded in 2020, operating in the healthcare technology sector. The company emerged from the Mayo Clinic Platform Accelerate program and aims to organize and expand the world's collective medical knowledge. Key leadership includes Daniel Nadler, PhD, a TIME100 Most Influential Person in Health, and a team of experts from prestigious institutions such as Harvard and MIT.

### ## Business Model and GTM
OpenEvidence provides a free medical information platform for verified U.S. healthcare professionals (HCPs), aggregating and synthesizing clinical findings from reputable sources like The New England Journal of Medicine and JAMA. The platform is available on both iOS and Android, facilitating easy access to critical medical research and evidence-based decision-making tools.

### ## Funding & Investor Profile
On an undisclosed date, OpenEvidence secured funding from a diverse group of investors, including Sequoia, Google Ventures, Kleiner Perkins, Coatue, Thrive, Conviction, ICONIQ, Greycroft, Breyer Capital, BOND, and Blackstone, as well as the Mayo Clinic. Total funding raised remains undisclosed, and the company's valuation has not been made public.

### ## Growth Momentum
As of the latest update, OpenEvidence reports a headcount of approximately 50 employees, with ongoing recruitment efforts indicating a focus on expanding its engineering and commercial teams. The company is actively hiring, with several open roles aimed at enhancing its technological capabilities and market reach. Notable product launches and partnerships have not been disclosed.

### ## Visibility & Market Sentiment
OpenEvidence has garnered significant attention, with 25 news mentions in the past 30 days and an average sentiment score of 0.68. The platform's visibility is further enhanced by its presence on social media and professional networks, although specific metrics such as GitHub stars or Glassdoor ratings are not available.

### ## Risks and Challenges
- Valuation not disclosed.
- Competitive pressure from other medical information platforms.
- Rapidly evolving healthcare technology landscape may pose challenges in maintaining relevance.

### ## Outlook
OpenEvidence is well-positioned for growth in the healthcare technology sector, given its strong backing from notable investors and its unique value proposition in addressing information overload in medicine. The ongoing hiring signals a commitment to scaling operations and enhancing product offerings, which aligns with the increasing demand for accessible medical knowledge.

### ## Disclosure Gaps
- Valuation not disclosed.
- Total funding amount not disclosed.
- Specific customer counts and detailed headcount growth metrics are not disclosed.